Skip to main content
Iranian Journal of Microbiology logoLink to Iranian Journal of Microbiology
. 2020 Dec;12(6):565–576. doi: 10.18502/ijm.v12i6.5031

Antibacterial properties of selected Malaysian Tualang honey against Pseudomonas aeruginosa and Streptococcus pyogenes

Mohammad Abdulraheem Al-Kafaween 1, Hamid Ali Nagi Al-Jamal 1,*, Abu Bakar Mohd Hilmi 1, Nour Amin Elsahoryi 2, Norzawani Jaffar 1, Mohd Khairi Zahri 1
PMCID: PMC7884280  PMID: 33613911

Abstract

Background and Objectives:

Tualang honey (TH) is a Malaysian multifloral jungle honey. In recent years, there has been a marked increase in the number of studies published in medical databases regarding its potential health benefits. The study aimed to investigate the effect of TH against Pseudomonas aeruginosa and Streptococcus pyogenes.

Materials and Methods:

The effect of TH on both bacteria was investigated using MIC, MBC, growth curve, time-kill curve, scanning electron microscopy (SEM) and RT-qPCR.

Results:

The MIC of TH against P. aeruginosa and S. pyogenes was 18.5% (w/v) and 13% (w/v) respectively and MBC was 25% (w/v) for both bacteria. Spectrophotometric readings of at least 90% inhibition yielded MIC90 values of TH, 18.5% (w/v) and 15% (w/v) for P. aeruginosa and S. pyogenes respectively. A time–kill curve demonstrated a bactericidal with a 4-log reduction estimated within 8 hours. Using SEM, loss of structural integrity and marked changes in cell shape were observed. RT-qPCR analysis showed that TH reduced the pattern of gene expression in both bacteria, with a trend toward reduced expression of the virulence genes of interest.

Conclusion:

This study suggests that TH could potentially be used as an alternative therapeutic agent for microbial infection particularly against these two organisms.

Keywords: Antibacterial activity, Tulang honey, Scanning electron microscopy, Differential expression

INTRODUCTION

Honey is one of the oldest traditional medicines that has been highly reputed and widely used for the treatment of several human diseases for thousands of years ago (1). This reputation has continued up to the present day, leading to the emergence of a relatively new branch of alternative medicine, called “apitherapy”, which focuses on medical applications of honey and other bee products (2, 3). Nowadays, different types of honey have been used in many countries as an alternative to pharmaceutical products for treating contaminated, infected, and burn wounds (36). This is attributed to the effectiveness of these honeys in inhibiting or killing a broad spectrum of bacteria (79). The antimicrobial activity of honey may be attributed to several factors, including high osmolarity, acidity, in addition to the presence of hydrogen peroxide (H2O2) (10) and non-peroxide components, such as methylglyoxal (11). In addition to exerting direct antimicrobial effects, some honey varieties have been implicated in the differential expression of a number of genes essential for bacterial survival and virulence, including those involved in stress tolerance (12), virulence factor production (13), as well as multicellular behaviors, such as biofilm formation (14, 15), and quorum sensing (16). To the best of our knowledge, only three published studies to date have focused on the honey-induced expression patterns in P. aeruginosa and S. pyogenes (15, 17, 18). Honey’s composition (and hence its antimicrobial activity) is dependent on the environmental and geographical locations from which the original nectar was collected (19, 20). This is attributed to natural variations in floral sources and climatic conditions at different locations (19). Therefore, several researchers have explored the therapeutic effects of honeys obtained from diverse geographical areas worldwide (2123). Several studies have addressed different aspects of honey varieties, including their physicochemical properties, chemical composition, antibacterial activity, and therapeutic usefulness (2430). However, it is not yet known whether these antibacterial activities, as well as any possible and anti-virulence activities possessed by these honeys could be attributed to alteration of bacterial gene expression. Therefore, the objectives of the present study were threefold: (i) to evaluate the direct antimicrobial activity of TH of the most common Malaysian honey against P. aeruginosa and S. pyogenes (ii) to study the effects of TH on the structure of P. aeruginosa and S. pyogenes (iii) to estimate the impacts of this honey on the expressions of virulence-related genes (in other words, to evaluate the anti-virulence potential of this honey).

MATERIALS AND METHODS

Honey sample.

Tualang honey (TH) samples was purchased from Kuala Terengganu a state in Malaysia and were used throughout this study. Stock samples 100% were stored in the dark bottles, labelled accordingly and stored at room temperature away from light source. Then, honey samples have been prepared freshly for each experiment and syringe filter (pore size 0.45 μm, diameter 25 mm) was used in this study (31). To ascertain the security of the purchased product, honey was presented to the bee hunters based on their geographical hunting area to identify the purity, reliability, and quality of the honey.

Bacterial strain and culture conditions.

Standard reference strains of Gram-negative bacteria P. aeruginosa (ATCC 10145) and Gram-positive bacteria S. pyogenes (ATCC 19615) were purchased from American type tissue culture (ATCC) and were used throughout this study. The bacteria samples were cultured and maintained on nutrient agar (NA; Oxoid, UK) and incubated at 37°C unless otherwise stated (32).

Minimum inhibitory concentration and minimum bactericidal concentration.

The minimum inhibitory concentration (MIC) of the TH was determined using the broth dilution method in sterile 96-well microtiter plates. Fifty percent (w/v) stock solution of TH was prepared by weighing 10 g of the honey and bringing the volume up to 20 ml using Nutrient broth (NB). Further dilutions were done to obtain honey concentrations of 6.25%, 7.5%, 8.75%, 9.25%, 10%, 11.25%, 12.5%, 13%, 15%, 16.5%, 17.5%, 18.5%, 20%, 22.5% and 25% (w/v). A few single bacterial colonies from an overnight culture on nutrient agar (NA) were inoculated into peptone water to achieve a turbidity of 0.5 McFarland (≈ 1 × 108 CFU/ml). Plates were incubated for 24 hours at 37°C and turbidity measured at 570 nm in a microplate reader (Tecan Infinite 200 PRO, Austria) Herein, the most common way to assess microbial growth in solution is the measurement of the optical density between 600 nm and 620 nm. In this study, we measured the turbidity at 570 nm, this wavelength was chosen from previous studies (3133) and based on absorbance detection mode and basically determines which portion of light passes through a sample, more specifically through a suspension of microorganisms). Inoculum only was used as a positive control, broth only was served as a negative control and honey without inoculum was used as corresponding negative control. Wells with the lowest concentration without growth were recorded as the MIC. The minimum bactericidal concentration (MBC) was determined by taking a loopful of the culture medium from each test well (from the broth MIC assay) that showed no apparent growth and sub-culturing on fresh nutrient agar (NA) plates. After incubation at 37°C for 24 hours, the MBC was read as the least concentration showing no growth on the NA plates (33). The growth inhibition for the test wells at TH dilution was determined by the formula as mentioned below (34).

Percentageofinhibition(%)=[1(ODtestwell-ODcorrespondingnegativecontrolwell)×100%(ODviabilitycontrolwellODbrothonlywell)]

Experiments were performed in triplicate.

Growth kinetics curves.

To determine the effects of TH on the growth curves of P. aeruginosa and S. pyogenes, the inoculum concentration was adjusted to 0.5 McFarland using a spectrophotometer. Cells were grown and treated in 96-well microtitre plates with MIC, half-MIC and quarter-MIC. The plate was incubated at 37°C for 24 hours. At 60 minutes intervals, the absorbance of wells were measured at 570 nm using a microplate readers (Tecan Infinite 200 PRO, Austria). The experiment was performed in triplicate for each bacteria tested (32).

Time-kill curve.

An overnight broth culture of each test organism in 15 ml NB was prepared by inoculating a colony from a pure culture and incubating at 37°C for 24 hours. After incubation, each culture was diluted with NB to an optical density of 0.5 at 600 nm. 60 ml of sterile NB was added to conical flask labelled as control for each isolate. A 60 ml of appropriate of TH solution (MIC) was prepared in another conical flask and labelled as test for each isolate. A 60 ml of appropriate of TH solution (2 × MIC) was prepared in another conical flask and labelled as test for each isolate. Then 6 ml from the diluted overnight culture was transferred into each flask. The mixture was then incubated at 37°C with shaking (100 rpm). One ml from each flask was removed into a microcuvette and absorbance was recorded at 570 nm 1 hour up to 8 hours (0, 1, 2, 3, 4, 5, 6, 7 and 8 hours). Finally, total viable count for each collected specimen was determined as follows: 30 μl of the specimen was diluted in a decimal dilution series from 10–1 to 10–10 using NB broth, plated on nutrient agar and were cultured for 24 hours at 37°C for determination of total bacterial count in each well. A graph mean of Log10 CFU/ml versus time was plotted for determination of total bacterial count in each well (35). The experiment was performed in triplicate for each bacteria tested.

Scanning electron microscopiy (SEM).

The effects of MIC TH on the morphology of P. aeruginosa and S. pyogenes was examined by SEM (JEOL 6360LA, Japan). Bacterial cultures were centrifuged (3500 rpm, 10 min) after 8 hours incubation with MIC TH at 37°C. Pellets were collected and were fixed overnight with 2.5% (v/v) glutaraldehyde in 0.01 M phosphate buffer solution (PBS). The samples were washed twice with 0.01 PBS for 5 minutes followed by deionized water for 10 minutes. All samples were dehydrated with ascending concentrations of ethanol for 10 minutes and subjected to critical point drying. The sample was then subsequently coated with platinum, placed onto the copper stage holder and examined by SEM (36).

RNA Extraction for RT-qPCR.

Initially, Mid-exponential phase P. aeruginosa and S. pyogenes cells were diluted 1:1 with NB, and NB containing MIC TH. Meanwhile, inoculum only without honey was served as a positive control. Subsequently, the samples were incubated for 8 hours in a shaking (100 rpm) at 37°C. After 8 hours incubation, 1 ml of sample treated and untreated were extracted and centrifuged at 13,000 rpm for 2 minutes. The supernatant was discarded and the pellet was washed with PBS. The pelleted cells were resuspended in 50 μl of lysozyme (Sigma-Aldrich, UK), and 50 μl mutanolysin (Sigma-Aldrich, UK) and then incubated at room temperature for 15 minutes. Total RNA from treated and untreated samples were extracted using kit SV Total RNA Isolation System (Promega, UK). Total RNA concentrations were examined using Implen NanoPhotometer® NP80. RNA purity levels were assessed using the 260/280 absorbance ratio, with only sample ratios between 1.8 and 2.1 being accepted for conversion to cDNA. Total RNA samples were converted to cDNA following the manufacturer’s instructions kit (Promega, UK). Samples were diluted to 100 ng/μl using ultra-pure water. For each reaction, qPCR mastermix was prepared by following the manufacturer’s instructions (Promega, UK) and PCR primers were used as shown in Tables 1 and 2 (15, 17, 32, 37, 38). The following PCR protocol was used: denaturation at 95°C for 2 minutes in one cycle, amplification at 95°C for 15 seconds in 40 cycles and a final elongation annealing at 60°C for 1 min in 40 cycles. Densitometry was performed using the Applied Biosystems StepOne Software v2.3. To determine and calculate the level of gene expression, a modified 2–ΔΔ Ct method was used (15, 32). The experiments were performed in triplicate.

Table 1.

Gene specific primers of P. aeruginosa used for RT-qPCR analysis (37, 38).

Gene name Amplicon Size (bp) Direction Primer sequence (5’ → 3’)
algD 144 Forward CGCCGAGATGATCAAGTACA
Reverse AGGTTGAGCTTGTGGTCCTG
oprF 101 Forward CTGGACGCCATCTACCACTT
Reverse CTGTCGCTGTTGATGTTGGT
fleN 137 Forward GAGCCGTATACGAGGCATTC
Reverse GTGTTGGACCAGTCGTTCG
fleQ 134 Forward AAGGACTACCTGGCCAACCT
Reverse CCGTACTTGCGCATCTTCTC
fleR 109 Forward ACAGCCGCAAGATGAACCT
Reverse TGGATGGCGTTGTCGAGTT
oprB 140 Forward GACGACGACAAGACAGGAC
Reverse GGTCGTTGGAAAGGTTCTTG
oprH 102 Forward CTCGACAAGGTGATCGACAA
Reverse GGTGTCGGAGATGTTCTCGT
fliA 192 Forward CTCCAATTGAGCCTCGAAGA
Reverse TTCGTTGTGACTGAGGCTGG
fliC 121 Forward GCTTCGACAACACCATCAAC
Reverse AGCACCTGGTTCTTGGTCAG
rpoD* 146 Forward GCGACGGTATTCGAACTTGT
Reverse CGAAGAAGGAAATGGTCGAG
*

Reference gene for P. aeruginosa

Table 2.

Gene specific primers of S. pyogenes used for RT-qPCR analysis (15, 17, 32).

Gene name Amplicon Size (bp) Direction Primer sequence (5’ → 3’)
Sof 873 Forward ACTTAGAAAGTTATCTGTAGGG
Reverse TCTCTCGAGCTTTATGGATAG
SfbI 960 Forward AACTGCTTTAGGAACAGCTTC
Reverse CCACCATAGCCACAATGCT
scpA 622 Forward GCTCGGTTACCTCACTTGTCC
Reverse CAATAGCAGCAAACAAGTCACC
ftsY 97 Forward TCGAAAATTCTTTGGCCTGT
Reverse ATCAAACGTGTTGTGCCAGA
emm13 373 Forward CGCCAGGGTTTTCCCAGTCACGAC
Reverse AGCGGATAACAATTTCACACAGGA
glr* 797 Forward ATGGATACAAGACCAATTGG
Reverse TCATAAGGTGACATGCTCCAC
*

Reference gene for S.pyogenes

Statistical analysis.

Data was expressed as mean ± standard deviation. Independent student t-test from (SPSS version 20) was used to compare between honey-treated and control groups. The significant was set at P<0.05.

RESULTS

Minimum inhibitory concentrations and minimum bactericidal concentrations.

Under visual inspection, the MIC and MBC for TH against P. aeruginosa were 18.5% (w/v) to 25% (w/v) respectively, while the MIC and MBC for TH against S. pyogenes were 13% (w/v) and 25% (w/v) respectively. When tested against P. aeruginosa and S. pyogenes, TH had equal MBC value (25% (w/v). Spectrophotometric readings of at least 90% inhibition (MIC90) gave MIC values for TH 18.5% (w/v) and 15% (w/v) against P. aeruginosa and S. pyogenes respectively. (Fig. 1 and Table 3).

Fig. 1.

Fig. 1.

Inhibition of the growth of P. aeruginosa and S. pyogenes caused by TH at different concentrations

Table 3.

MIC values (%) determined by visual inspection and spectrophotometric measurement and MBC values (%) of TH

Microorganism Visual MIC (%) Spectrophotometric MIC90 (%) MBC (%)
P. aeruginosa 18.5 18.5 25
S. pyogenes 13 15 25

Growth kinetics curves.

Growth kinetic curves of untreated P. aeruginosa and S. pyogenes demonstrated that under the experimental conditions, exponential phase occurred between 1 and 11 hours. P. aeruginosa and S. pyogenes samples treated with (MIC) TH demonstrated zero growth. Treatment with (half-MIC) TH resulted in an increased lag phase, decreased exponential phase and lower absorbance values during stationary phase. Conversely, treatment with (quarter-MIC) TH was observed to have a similar lag phase and exponential phase to untreated samples. However, the rate of exponential growth during the end of this growth phase appeared greater, resulting in higher absorbance values during early stationary phase, subsiding below that of untreated samples with the onset of death phase (Fig. 2).

Fig. 2.

Fig. 2.

Growth kinetics curve of P. aeruginosa and S. pyogenes cells grown with (MIC, half-MIC and quarter-MIC) and without TH

Time kill curve.

The time-kill curve clearly shows an increase in number of P. aeruginosa and S. pyogenes cells without TH treatment. However, MIC TH resulted in 2.36-log10 and 2.48-log10 reduction in CFU/ml of P. aeruginosa and S. pyogenes cells respectively compared to the starting inoculum at 8 hours incubation. Therefore, P. aeruginosa and S. pyogenes incubated with 2 × MIC TH in 3.51-log10 and 3.64-log10 reduction in CFU/ml respectively compared to the starting inoculum at 8 hours incubation. Although, the mean difference in number of colony forming units between non-honey and honey treated were statistically significant (P <0.05). The MIC and MBC were confirmed by growth kinetics curves and time–kill studies, where cells exposed to tualang and TH were found to lose viability with time, yet the numbers of untreated cells increased. The time estimated to achieve a 4 log reduction of both bacteria incubated with MIC and 2 × MIC (w/v) TH was 8 hours (Fig. 3).

Fig. 3.

Fig. 3.

Culturability of P. aeruginosa and S. pyogenes samples grown with (MIC and 2 × MIC) and without TH

Scanning electron microscopy (SEM).

SEM micrograph of untreated cells of P. aeruginosa incubated with broth only was observed to have a regular rod shaped cell with a smooth surface and normal cell size. However, after 8 hours incubation with MIC TH this bacterium appeared enlarged and elongated. Honey-treated cells also appeared to be shortened and to have distorted shapes. In addition, clumping and cell aggregation increased. This suggests that the effect of TH on P. aeruginosa is not due exclusively to the sugars contained in honey (Fig. 4).

Fig. 4.

Fig. 4.

SEM micrographs of P. aeruginosa cells exposed to MIC TH at 10,000× magnification. P. aeruginosa incubated with broth only (A and B). P. aeruginosa incubated with MIC TH (C and D).

SEM micrograph of S. pyogenes incubated with broth alone (no honey) was found to have a conventional cocci shape after 8 hours incubation in liquid media. In SEM micrographs of MIC TH treated cells, cell size and shape appear to be different to untreated cells. However, cell size increased after exposure to TH. In addition, morphological changes, in which the lysed cells started to clump together as compared to typical spherical morphology of S. pyogenes (Fig. 5).

Fig. 5.

Fig. 5.

SEM micrographs of S. pyogenes cells exposed to MIC TH at ×10,000 magnification. S. pyogenes incubated with broth only (A and B. S. pyogenes cells incubated with MIC TH (C and D).

Effects of TH on the mRNA expression of P. aeruginosa.

In the present study, RT=qPCR was used to evaluate and compare the impacts of exposure of P. aeruginosa and S. pyogenes cells to TH (at MIC; for 8 h) on the expression of genes that have been previously shown to be involved in virulence of the microorganisms. As revealed by the t-test (SPSS version 20), there was a significant overall difference (P <0.05) in the expression of each of the tested genes among the different groups. All genes were down-regulated following exposure to TH under study though different degrees of down-regulation were observed following exposure to MIC TH. Two (algD and oprF) microcolony forming-associated genes investigated showed a statistically significant reduction (P <0.05) in gene expression with 0.33-fold change and 0.31-fold change following treatment with MIC TH respectively. Five (fleN, fleQ, fleR, fliA and fliC) of the flagellum-associated genes investigated showed a statistically significant reduction (P <0.05) in gene expression following treatment with MIC TH. This suggests that TH inhibits flagellum gene expression by impacting on both regulatory (fleN, fleQ, fleR and fliA). Following treatment with MIC TH there was a significant reduction (P <0.05) in gene expression of oprB and oprH that involved in the outer. The fold change of mRNA transcripts of oprB and oprH that was 0.22-fold and 0.43-fold following treatment with MIC TH respectively (Fig. 6).

Fig. 6.

Fig. 6.

mRNA expression of genes in P. aeruginosa following treatment with MIC TH. Results are expressed as the mean fold change (control standardised to 1.0) with error bars (* P <0.05).

Effects of TH on the mRNA expression of S. pyogenes.

The major genes encoding the surface adhesins sof, sf bl, scpA, ftsY and emm13 in S. pyogenes showed different degrees of down-regulation in response to MIC TH. Following treatment with MIC TH there was a significant reduction (P <0.05) in the expression of mRNA transcripts for sof, sf bl, scpA, ftsY and emm13 in S. pyogenes (Fig. 7).

Fig. 7.

Fig. 7.

mRNA expression of genes in S. pyogenes following treatment with MIC TH. Results are expressed as the mean fold change (control standardised to 1.0) with error bars (* P <0.05).

DISCUSSION

The therapeutic potential of uncontaminated, pure honey is grossly underutilized. It is widely available in most communities and although the mechanism of action of several of its properties remain obscure and needs further investigation, the time has now come for conventional medicine to lift the blinds off this traditional remedy (39). This study was carried out to evaluate the efficacy of TH in the inhibition of P. aeruginosa and S. pyogenes. The antibacterial potency of each honey was determined by MIC and MBC, growth curve, time-kill study, SEM and RT-qPCR. Each experiment provided some insight into possible inhibitory mechanisms of TH on both bacteria. Tualang honey (TH) is readily available in Malaysia, but its quality and floral origin have yet to be determined and standardized. In this study, we found that TH has variable broad-spectrum activities against P. aeruginosa and S. pyogenes. We chose the broth dilution method for this study because it generates more quantitative and precise results compared to the agar well diffusion method. Moreover, the MIC values determined by the broth dilution method might be accurate (indicating higher activity) than those obtained using the agar well diffusion method, as diffusion rates of active constituents in agar may be slower than those in broth (40). We also performed spectrophotometric assays using microtiter plates; it is a simple and rapid method, it has a greater sensitivity than the standard well and disc diffusion methods and the results are highly reproducible (41). Spectrophotometry can detect inhibitory levels below those recorded for well or disc diffusion assays (41). Historically, both MIC and MBC values have been used as indicators of bacteriostatic or bactericidal activity for antimicrobial compounds. The TH used in this study had MIC values of 18.5% and 13% (w/v), for P. aeruginosa and S. pyogenes respectively and had MBC value of 25% (w/v) for both bacteria. Thus, more effective treatment is needed to treat P. aeruginosa and S. pyogenes. Analysis of the inhibition of bacterial growth caused by different honey concentrations revealed the differences in the pattern of inhibition exhibited by both bacteria. The observed differences might reflect how each type of bacteria reacts to honey treatment. Growth analysis confirmed MIC concentrations and identified disparate growth curves for both bacteria treated with sub-in-hibitory concentration of TH, suggesting the sugar and antimicrobial fractions are affected differently by the dilution factor. Decreased growth was observed in bacteria treated with TH at half-MIC, indicating the antimicrobial fraction, whilst diluted, still retained inhibitory activity. Time-kill curves studies are used to measure the killing rate of organism by TH using time and concentration. A bactericidal activity is defined as in vitro activity of 3 log reduction in the CFU/ml or 99.9% killing over a specific period of time (42). Killing measurement was made in this study by the actual decrease in viable counts at 8 h for both bacteria. There was significant differences between treated and untreated TH sample (P <0.05). The loss of structural integrity in P. aeruginosa and S. pyogenes treated with TH was observed and cells under SEM images were short, distorted and displayed cell surface abnormalities. Previous study is in agreement with our finding showed that loss of structural integrity and marked changes in cell shape of P. aeruginosa after exposure to manuka honey (36). Previous study revealed that Trigona honey had decreased cell density, and cells appeared curved of P. aeruginosa and rough, holes and crevices of S. pyogenes (33). The analysis of gene expression found differential expression of algD, oprF, fleN, fleQ, fleR, fliA and fliC genes of P. aeruginosa when TH was applied, suggesting the impact of TH on numerous aspects of the flagellar regulon. In turn, the differential suppression of fliC and fliA occurred. Hence, the repression of flagella-associated genes allows TH to mediate the de-flagellation of P. aeruginosa, which leads to decreased motility, adherence and virulence. In addition, it is likely that the reduced expression of the three outer membrane proteins (oprB, oprH and oprF) caused the reduced survivability of P. aeruginosa. As demonstrated by RT-qPCR, the expression of sof, sf bl, scpA, ftsY and emm13 genes had decreased. These genes are the major genes encoding the surface adhesins in S. pyogenes, the decreased expression of these genes in S. pyogenes following the TH treatment might show that the TH restricts the growth and biofilm formation of S. pyogenes. Among the physicochemical parameters of honey, the acidity and the osmolarity represent the principal factors responsible for the antimicrobial activity of honey. However, there are other factors that are closely related to the antimicrobial capacity of honey such as the hydrogen peroxide content, and other non-peroxide components such as methylglyoxal, the antimicrobial peptide bee defensin-1, polyphenols and other compounds from the bees (43).

CONCLUSION

TH exhibited variable activities against both bacteria. In some cases, it showed equivalent or better activities against Gram-positive bacteria than Gram-negative bacteria. The potency of TH against certain microorganisms suggests its potential to be used as an alternative therapeutic agent for certain medical conditions, particularly wound infection. Together, our results revealed that the tested TH has the potential to be effective inhibitors of P. aeruginosa and S. pyogenes. Differential gene expression in response to TH exposure exhibited downregulation of several virulence genes of P. aeruginosa and S. pyogenes. The obtained results indicate that the TH under study may represent promising antibacterial and anti-virulence agents for treatment and modulation of infections caused by P. aeruginosa and S. pyogenes. Further investigation into its effect on cellular and molecular targets is warranted, and its clinical efficacy must be confirmed.

ACKNOWLEDGEMENTS

The authors would like to thank staff laboratory members of the Faculty of Health, UniSZA.

REFERENCES

  • 1.Pećanac M, Janjić Z, Komarčević A, Pajić M, Dobanovački D, Mišković-Skeledžija S. Burns treatment in ancient times. Med Pregl 2013;66:263–267. [PubMed] [Google Scholar]
  • 2.Majtán J. [Apitherapy--the role of honey in the chronic wound healing process]. Epidemiol Mikrobiol Imunol 2009; 58:137–140. [PubMed] [Google Scholar]
  • 3.Vandamme L, Heyneman A, Hoeksema H, Verbelen J, Monstrey S. Honey in modern wound care: a systematic review. Burns 2013;39:1514–1525. [DOI] [PubMed] [Google Scholar]
  • 4.Lotfy M, Badra G, Burham W, Alenzi F. Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus. Br J Biomed Sci 2006;63:171–173. [DOI] [PubMed] [Google Scholar]
  • 5.Subrahmanyam M. A prospective randomised clinical and histological study of superficial burn wound healing with honey and silver sulfadiazine. Burns 1998;24:157–161. [DOI] [PubMed] [Google Scholar]
  • 6.Kumar A, Cascarini L, McCaul JA, Kerawala CJ, Coombes D, Godden D, et al. How should we manage oral leukoplakia. Br J Oral Maxillofac Surg 2013;51:377–383. [DOI] [PubMed] [Google Scholar]
  • 7.Lusby PE, Coombes AL, Wilkinson JM. Bactericidal activity of different honeys against pathogenic bacteria. Arch Med Res 2005;36:464–477. [DOI] [PubMed] [Google Scholar]
  • 8.Molan PC. The antibacterial activity of honey: 1. The nature of the antibacterial activity. Bee World 1992;73:5–28. [Google Scholar]
  • 9.Mundo MA, Padilla-Zakour OI, Worobo RW. Growth inhibition of foodborne pathogens and food spoilage organisms by select raw honeys. Int J Food Microbiol 2004;97:1–8. [DOI] [PubMed] [Google Scholar]
  • 10.Brudzynski K, Abubaker K, Castle A. Re-examining the role of hydrogen peroxide in bacteriostatic and bactericidal activities of honey. Front Microbiol 2011;2:213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mavric E, Wittmann S, Barth G, Henle T. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res 2008;52:483–489. [DOI] [PubMed] [Google Scholar]
  • 12.Revello MG, Gorini G, Zavattoni M, Furione M, Gerna G. Congenital rubella infection following rubella out-break in northern Italy, 2002: need for an effective vaccination programme. Eur J Clin Microbiol Infect Dis 2004;23:780–783. [DOI] [PubMed] [Google Scholar]
  • 13.Jenkins R, Burton N, Cooper R. Proteomic and genomic analysis of methicillin-resistant Staphylococcus aureus (MRSA) exposed to manuka honey in vitro demonstrated down-regulation of virulence markers. J Antimicrob Chemother 2014;69:603–615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Abbas HA. Comparative antibacterial and antibiofilm activities of manuka honey and Egyptian clover honey. Asian J Appl Sci 2014;2:110–115. [Google Scholar]
  • 15.Roberts AE, Maddocks SE, Cooper RA. Manuka honey is bactericidal against Pseudomonas aeruginosa and results in differential expression of oprF and algD. Microbiology (Reading) 2012;158:3005–3013. [DOI] [PubMed] [Google Scholar]
  • 16.Wang R, Starkey M, Hazan R, Rahme L. Honey’s ability to counter bacterial infections arises from both bactericidal compounds and QS inhibition. Front Microbiol 2012;3:144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Maddocks SE, Lopez MS, Rowlands RS, Cooper RA. Manuka honey inhibits the development of Streptococcus pyogenes biofilms and causes reduced expression of two fibronectin binding proteins. Microbiology (Reading) 2012;158:781–790. [DOI] [PubMed] [Google Scholar]
  • 18.Roberts AE, Maddocks SE, Cooper RA. Manuka honey reduces the motility of Pseudomonas aeruginosa by suppression of flagella-associated genes. J Antimicrob Chemother 2015;70:716–725. [DOI] [PubMed] [Google Scholar]
  • 19.Elbanna K, Attalla K, Elbadry M, Abdeltawab A, Gamal-Eldin H, Ramadan MF. Impact of floral sources and processing on the antimicrobial activities of different unifloral honeys. Asian Pac J Trop Dis 2014;4:194–200. [Google Scholar]
  • 20.Wasfi R, Elkhatib WF, Khairalla AS. Effects of selected Egyptian honeys on the cellular ultrastructure and the gene expression profile of Escherichia coli. PLoS One 2016;11(3):e0150984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lu J, Carter DA, Turnbull L, Rosendale D, Hedderley D, Stephens J, et al. The effect of New Zealand kanuka, manuka and clover honeys on bacterial growth dynamics and cellular morphology varies according to the species. PLoS One 2013;8(2):e55898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Anthimidou E, Mossialos D. Antibacterial activity of Greek and Cypriot honeys against Staphylococcus aureus and Pseudomonas aeruginosa in comparison to manuka honey. J Med Food 2013;16:42–47. [DOI] [PubMed] [Google Scholar]
  • 23.Ng W, Ken K-W, Kumar R-V, Gunasagaran H, Chandramogan V, Lee Y-Y. In-vitro screening of Malaysian honey from different floral sources for antibacterial activity on human pathogenic bacteria. Afr J Tradit Complement Altern Med 2014;11:315–318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Boorn K, Khor YY, Sweetman E, Tan F, Heard T, Hammer K. Antimicrobial activity of honey from the stingless bee Trigona carbonaria determined by agar diffusion, agar dilution, broth microdilution and time-kill methodology. J Appl Microbiol 2010;108:1534–1543. [DOI] [PubMed] [Google Scholar]
  • 25.Zulkhairi Amin FA, Sabri S, Mohammad SM, Ismail M, Chan KW, Ismail N, et al. Therapeutic properties of stingless bee honey in comparison with european bee honey. Adv Pharmacol Sci 2018;2018:6179596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kustiawan PM, Puthong S, Arung ET, Chanchao C. In vitro cytotoxicity of Indonesian stingless bee products against human cancer cell lines. Asian Pac J Trop Biomed 2014;4:549–556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tan HT, Rahman RA, Gan SH, Halim AS, Asma’Hassan S, Sulaiman SA, et al. The antibacterial properties of Malaysian tualang honey against wound and enteric microorganisms in comparison to manuka honey. BMC Complement Altern Med 2009;9:34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Irish J, Blair S, Carter DA. The antibacterial activity of honey derived from Australian flora. PLoS One 2011;6(3):e18229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Biluca FC, Braghini F, Gonzaga LV, Costa ACO, Fett R. Physicochemical profiles, minerals and bioactive compounds of stingless bee honey (Meliponinae). J Food Compost Anal 2016;50:61–69. [Google Scholar]
  • 30.Al-Hatamleh MA, Boer JC, Wilson KL, Plebanski M, Mohamud R, Mustafa MZ. Antioxidant-based medicinal properties of stingless bee products: recent progress and future directions. Biomolecules 2020;10:923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Al-Kafaween MA, Hilmi ABM, Khan RS, Bouacha M, Amonov M. Effect of Trigona honey on Escherichia coli cell culture growth: In vitro study. J Apither 2019;5:10–17. [Google Scholar]
  • 32.Al-kafaween MA, Hilmi ABM, Jaffar N, Al-Jamal HAN, Zahri MK, Amonov M, et al. Effects of Trigona honey on the gene expression profile of Pseudomonas aeruginosa ATCC 10145 and Streptococcus pyogenes ATCC 19615. Jordan J Biol Sci 2020;13: 133–138. [Google Scholar]
  • 33.Al-kafaween MA, Hilmi ABM, Jaffar N, Al-Jamal HAN, Zahri MK, Jibril FI. Antibacterial and anti-biofilm activities of Malaysian Trigona honey against Pseudomonas aeruginosa ATCC 10145 and Streptococcus pyogenes ATCC 19615. Jordan J Biol Sci 2020;13:69–76. [Google Scholar]
  • 34.Zainol MI, Yusoff KM, Yusof MYM. Antibacterial activity of selected Malaysian honey. BMC Complement Altern Med 2013;13:129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Bouacha M, Ayed H, Grara N. Honey bee as alternative medicine to treat eleven multidrug-resistant bacteria causing urinary tract infection during pregnancy. Sci Pharm 2018;86:14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Henriques A, Jenkins R, Burton N, Cooper R. The effect of manuka honey on the structure of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 2011;30:167–171. [DOI] [PubMed] [Google Scholar]
  • 37.Roberts AE, Maddocks SE, Cooper RA. Manuka honey reduces the motility of Pseudomonas aeruginosa by suppression of flagella-associated genes. J Antimicrob Chemother 2015;70:716–725. [DOI] [PubMed] [Google Scholar]
  • 38.Roberts AEL. (2014). The inhibition of Pseudomonas aeruginosa by manuka honey: Cardiff Metropolitan University Thesis. [Google Scholar]
  • 39.Zumla A, Lulat A. (1989). Honey-a remedy rediscovered. SAGE Publications Sage UK: London England. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Okeke MI, Iroegbu CU, Eze E, Okoli A, Esimone C. Evaluation of extracts of the root of Landolphia owerrience for antibacterial activity. J Ethnopharmacol 2001;78:119–127. [DOI] [PubMed] [Google Scholar]
  • 41.Patton T, Barrett J, Brennan J, Moran N. Use of a spectrophotometric bioassay for determination of microbial sensitivity to manuka honey. J Microbiol Methods 2006;64:84–95. [DOI] [PubMed] [Google Scholar]
  • 42.Shrivastava SM, Kumar S, Chaudhary M. Time-kill curve studies of Ampucare against Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae and Proteus vulgaris. Res J Med Plant 2009; 3:116–122. [Google Scholar]
  • 43.Bucekova M, Buriova M, Pekarik L, Majtan V, Majtan J. Phytochemicals-mediated production of hydrogen peroxide is crucial for high antibacterial activity of honeydew honey. Sci Rep 2018; 8:9061. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Iranian Journal of Microbiology are provided here courtesy of Tehran University of Medical Sciences

RESOURCES